Login Register Cart 0
Generic placeholder image

CNS & Neurological Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5273
ISSN (Online): 1996-3181

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine

Author(s): Ismail Rammouz*, Jalal Doufik, Rachid Aalouane and Saïd Boujraf

Volume 22, Issue 4, 2023

Published on: 16 September, 2022

Page: [618 - 621] Pages: 4

DOI: 10.2174/1871527321666220829112733

Price: $65

Abstract

Introduction: Several COVID-19 vaccines have been implemented. However, some side effects of the vaccine have been reported, which are sometimes very harmful. Reported cases and data are still very limited regarding the psychiatric side effects of the COVID-19 vaccine. To our knowledge, only one case has been reported. In this paper, we report the case of a patient who presented an acute depressive episode 24 hours after receiving his first dose of the BNT162b2mRNA vaccine.

Case Report: The case was a 26-year-old man with a history of Down syndrome with moderately good autonomy for daily routine tasks. The patient, who presented hypothyroidism at 10 years old and schizophrenia at 15 years old, was doing well before the vaccination and received his first dose of the BNT162b2mRNA vaccine. Twenty-four hours later, he presented depressive symptoms that resolved spontaneously after one week. Then, fifteen days later, the symptoms reappeared, and the episode lasted for 5 weeks. The patient received 10 mg/day of escitalopram besides his usual treatment. The depressive symptoms improved considerably by the second day of treatment.

Discussion: The presented case illustrated significant diagnostic challenges, especially when taking into account the sequential relationship between the COVID-19 vaccine and the occurrence of depressive symptoms. A single case of depression has been reported after the administration of the COVID-19 vaccine. Scientific evidence suggests the important role of the immune system in the pathophysiology of various psychiatric disorders, including depression.

Conclusion: Health professionals must take into consideration the potential psychiatric side effects even being rare so far, especially in vulnerable subjects. Further studies are required to establish the causal effects of depressive symptoms occurring during the weeks following the COVID-19 vaccine bolus injection.

Keywords: Side effects, vaccine, BNT162b2mRNA, COVID-19, depression, co-morbidities.

« Previous
[1]
Marshall M, Ferguson ID, Lewis P, et al. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics 2021; 148(3): e2021052478.
[http://dx.doi.org/10.1542/peds.2021-052478] [PMID: 34088762]
[2]
Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna SARS‐CoV ‐2 vaccination. Am J Hematol 2021; 96(5): 534-7.
[http://dx.doi.org/10.1002/ajh.26132] [PMID: 33606296]
[3]
McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad Dermatol 2021; 85(1): 46-55.
[http://dx.doi.org/10.1016/j.jaad.2021.03.092] [PMID: 33838206]
[4]
Uvais NA. Depression following ChAdOx1-S/nCoV-19 vaccine. Eur J Psychiatry 2022; 36(2): 140-1.
[http://dx.doi.org/10.1016/j.ejpsy.2021.08.001] [PMID: 34608345]
[5]
Veer IM, Riepenhausen A, Zerban M, et al. Psycho-social factors associated with mental resilience in the corona lockdown. Transl Psychiatry 2021; 11(1): 67.
[http://dx.doi.org/10.1038/s41398-020-01150-4] [PMID: 33479211]
[6]
Lu L, Xiong W, Mu J, et al. The potential neurological effect of the COVID-19 vaccines: A review. Acta Neurol Scand 2021; 144(1): 3-12.
[http://dx.doi.org/10.1111/ane.13417] [PMID: 33779985]
[7]
Yesilkaya UH, Sen M, Tasdemir BG. A novel adverse effect of the BNT162b2 mRNA vaccine: First episode of acute mania with psychotic features. Brain Behav Immun Health 2021; 18: 100363.
[http://dx.doi.org/10.1016/j.bbih.2021.100363] [PMID: 34632429]
[8]
Guo X, Jiang K. Is Depression the result of immune system abnormalities? Shanghai Jingshen Yixue 2017; 29(3): 171-3.
[http://dx.doi.org/10.11919/j.issn.1002-0829.217015] [PMID: 28904512]
[9]
Sharpley AL, Cooper CM, Williams C, Godlewska BR, Cowen PJ. Effects of typhoid vaccine on inflammation and sleep in healthy participants: A double-blind, placebo-controlled, crossover study. Psychopharmacology (Berl) 2016; 233(18): 3429-35.
[http://dx.doi.org/10.1007/s00213-016-4381-z] [PMID: 27503474]
[10]
Kuhlman KR, Robles TF, Dooley LN, Boyle CC, Haydon MD, Bower JE. Within-subject associations between inflammation and features of depression: Using the flu vaccine as a mild inflammatory stimulus. Brain Behav Immun 2018; 69: 540-7.
[http://dx.doi.org/10.1016/j.bbi.2018.02.001] [PMID: 29458196]
[11]
Collacott RA, Cooper SA, McGrother C. Differential rates of psychiatric disorders in adults with Down’s syndrome compared with other mentally handicapped adults. Br J Psychiatry 1992; 161(5): 671-4.
[http://dx.doi.org/10.1192/bjp.161.5.671] [PMID: 1422617]
[12]
Walker JC, Dosen A, Buitelaar JK, Janzing JGE. Depression in Down syndrome: A review of the literature. Res Dev Disabil 2011; 32(5): 1432-40.
[http://dx.doi.org/10.1016/j.ridd.2011.02.010] [PMID: 21392935]
[13]
Bode H, Ivens B, Bschor T, Schwarzer G, Henssler J, Baethge C. Association of hypothyroidism and clinical depression. JAMA Psychiatry 2021; 78(12): 1375-83.
[http://dx.doi.org/10.1001/jamapsychiatry.2021.2506] [PMID: 34524390]

Rights & Permissions Print Cite
Article Metrics
32
3
© 2024 Bentham Science Publishers | Privacy Policy